SYNOPSIS A study is reported of the estimation of plasma chloride concentration and acid-base status in the differentiation of primary hyperparathyroidism from all other causes of hypercalcaemia. In the two groups of patients studied, all of whom had hypercalcaemia, there was complete separation between the two groups on the basis of plasma chloride concentration and acid-base status. In 16 patients with primary hyperparathyroidism the increase in plasma chloride concentration and associated metabolic acidosis could have been accounted for by the known renal tubular effects of parathyroid hormone. In 13 patients with hypercalcaemia due to various other causes the decrease in plasma chloride concentration and associated metabolic alkalosis could be accounted for either by the known effects of an excess of calcium-ion on the renal tubules, or perhaps by suppression of endogenous parathyroid hormone secretion. In patients with hypercalcaemia and hypophosphataemia of 'pseudohyperparathyroidism' associated with non-endocrine tumours it is postulated that the low plasma chloride concentrations and metabolic alkalosis found in these patients were due either to a differing biological activity of the parathyroid-hormone-like polypeptide secreted by the tumour cells, or possibly to simultaneous secretion by these cells of an ACTH-like polypeptide.
The group, whose ages ranged from 21 to 36 years, comprised eight males and four females.
HYPERPARATHYROID PATIENTS
Sixteen patients with hypercalcaemia due to primary hyperparathyroidism were studied; in all of these the diagnosis was later proven by surgical exploration of the neck and histological examination of the adenoma.
HYPERCALCAEMIC PATIENTS
Thirteen patients with hypercalcaemia due to causes otherthanprimaryhyperparathyroidismwerestudied. The final diagnoses in these patients were carcinoma (5), vitamin D overdose (3), multiple myelomatosis (3), sarcoidosis (1), and Paget's disease (1). In four of the patients with carcinoma the hypercalcaemia was associated with osteolytic bone metastases from a primary carcinoma in the breast. In the fifth patient the hypercalcaemia was associated with a squamous-cell carcinoma of the bronchus, and in this patient there were no bone metastases seen on extensive radiographic survey. This patient may be classified as a case of 'pseudo-hyperparathyroidism' due to the secretion of a parathyroid-like polypeptide by a non-endocrine tumour.
Methods
All estimations were performed on 'arterializedvenous' blood specimens which were collected by the author. The samples were drawn from the back of the hand, after immersion in water (approximately 5000 for a minimum time of five minutes. The samples were collected anaerobically, without stasis, into a plastic syringe, the dead space of which was filled with heparin (Evans heparin 1,000 units per ml).
pH measurements were made on whole blood at 37°C with a capillary glass electrode (E.I.L.1 model SHH 33).
PCO, measurements were made on whole blood using a Severinghaus PCO2 electrode (E.I.L.1 model 9987 100). Plasma bicarbonate concentrations were measured on a Natelson micro-gasometer (Natelson, 1951) .
Plasma calcium concentration (total) was measured in a few of the earlier patients by the method of Wills and Gray (1964) and in the majority of the patients and all the normal subjects by the method of Lewin, Wills, and Baron (1969) .
Plasma phosphorus concentration was estimated by the method of Fiske and Subbarow (1925) .
Total plasma proteins were estimated by the biuret method of Wolfson, Cohn, Calvary, and Ichiba (1948) . 'Electronic Instruments Ltd, Richmond, Surrey M. R. Wills
Blood urea concentrations were measured by a diacetyl monoxime method on the AutoAnalyzer (method file N-1C3.
Plasma sodium and potassium concentrations were estimated by flame photometry (EEL2 clinical flame photometer model 150).
Plasma chloride concentrations were measured colorimetrically with an EEL2 chloride meter.
Results
The full results obtained in the patients with hypercalcaemia due to primary hyperparathyroidism and in those with hypercalcaemia due to various other causes are given in Tables I and II respectively. The tables also show the values of the mean ± SD for the normal subjects, their comparison with the patients by Student's t index, and the significance (p) of the t values. In both groups of patients the mean blood urea concentrations were higher than in the normal subjects; in view of the skew nature of the distribution of the values they have not been compared statistically. A comparison by Student's t index of the two patient groups is shown in Table m , together with the significance (p) of the t values.
In neither of the groups of patients was there a significant difference for the plasma phosphorus concentrations when compared with the normal subjects. In the patients with primary hyperparathyroidism the mean (± SD) plasma phosphorus concentration was 2-81 (± 0-78) mg per 100 ml, which differed significantly from the mean (± SD) of 3.54 (± 0 98) mg per 100 ml for the patients with hypercalcaemia due to various other causes. The individual results for plasma phosphorus concentration in these two groups are shown plotted against plasma calcium concentration in Figure 1 . Figure 1 shows that although the mean values for the two groups differed significantly there was no clear-cut difference for the individual values between the two groups on the basis ofplasma phosphorus concentration. The failure to demonstrate hypophosphataemia inallofthepatientswithprimaryhyperparathyroidism was probably, in part, due to renal damage, as in this group the mean blood urea concentration was higher than in the group of normal subjects. There was also a difference between the two groups of patients for the mean blood urea concentration with a higher value in the group of patients with hypercalcaemia when compared with the patients with primary hyperparathyroidism.
There was a significant difference in the plasma chloride concentration between the two groups of patients, and between both of the groups of patients when compared individually with the normal subjects. In the patients with primary hyperparathyroidism two groups show an almost clear-cut separation the mean (± SD) plasma chloride concentration of between them at a concentration of 102 m-equiv per 106-9 (± 5-4) m-equiv per litre was significantly litre. Among the 16 patients with primary hyperhigher than the mean (± SD) of 99-6 (± 3-0) parathyroidism there were two patients with values m-equiv per litre found in the patients with hyper-below that concentration, and none of the values in calcaemia due to various other causes. The individual the 13 patients with hypercalcaemia due to various results for plasma chloride concentration in these other causes were above that concentration. The difference in the mean plasma chloride concentration between the two groups of patients was 13-2 m-equiv per litre (Table III) , and was in the main part accounted for by the significant difference in the plasma bicarbonate concentration of 6-41 m-equiv per litre. The remaining 'gap' was accounted for, in part, by the differences in mean sodium (3-3 m-equiv per litre), potassium (0-34 m-equiv per litre), phosphorus (0-73 mg per 100 ml 3 0-42 m-equiv per litre), and protein concentration (0-57 g per 100 ml -1 38 m-equiv per litre), although these differences, with the exception of that for phosphorus, between the two groups were not significant. The absence of a greater increase in the plasma bicarbonate concentrations in the non-hyperparathyroid patients was presumably due to the accumulation of 'organic acid' metabolites, due to renal insufficiency, which was reflected in the higher blood urea concentrations in this group when compared with both the normal subjects and the patients with primary hyperparathyroidism.
The changes in plasma chloride concentration were predominantly represented by a difference in acid-base status between the two groups of patients, and also on comparison with the normal subjects. In the patients with primary hyperparathyroidism the values for both blood pH, PCO2, and bicarbonate concentrations were significantly lower (Table IIl) than those found in the patients with hypercalcaemia due to other causes. The individual results for blood pH, PCO2, and plasma bicarbonate concentration for the two groups of patients are shown plotted in Figure 2 . It can be seen from Fig. 2 that there was a clear-cut difference between the two groups on a basis of blood pH, with an overlap between the two groups in respect of the PCO2 values, and less marked overlap for the plasma bicarbonate concentrations.
Discussion
In the patients reported here, all of whom had hypercalcaemia, there was complete separation between those with hypercalcaemia due to primary hyperparathyroidism and those with hypercalcaemia due to all other causes on the basis of plasma chloride concentration and acid-base status. The changes in plasma chloride concentration are in accordance with our previously reported studies (Wills and McGowan, 1963; Wills, 1964; Wills and McGowan, 1964a) . The changes in plasma chloride concentrations were associated with a metabolic alkalosis in the patients with hypercalcaemia due to causes other than primary hyperparathyroidism and a metabolic acidosis in the latter group, which confirms our preliminary report (Wills and McGowan, 1964b) , although of the patients with primary hyperparathyroidism six of them had blood pH values within the lower half of the range obtained in the normal subjects.
In order to account for changes in acid-base status and plasma chloride concentrations, which ranged in the latter case from normal to high values in the hyperparathyroid group group.bmj.com on June 19, 2017 -Published by http://jcp.bmj.com/ Downloaded from evidence to suggest that this factor was operative in either group, which is also excluded by the acid-base findings.
From a consideration of these factors it would appear that the changes in plasma chloride concentration and acid-base status are due either to some alteration at the renal tubular level or are possibly related to the liberation of bone salt. Heinemann (1965) postulated that the metabolic alkalosis, found in patients with hypercalcaemia due to neoplastic disease, was due to the increased liberation of phosphate base from bone. In the hyperparathyroid patients with bone disease bone salts would presumably also be released, and the higher plasma chloride concentrations in this group may simply be due to the opposing action of a renal tubular acidosis. It is also possible that in these patients the rate of bone resorption is relatively slower than that in the patients with hypercalcaemia due to other causes. If release of bone salts was a major factor in the aetiology of the chloride and acid-base changes, a difference would be expected between the patients with bone disease in primary hyperparathyroidism when compared with those with renal stones. A comparison of the mean values for pH, PCO2, bicarbonate, and chloride concentration between these two types of primary hyperparathyroidism is shown in Table IV (Nordin, 1960; Hellman, Au, and Bartter, 1965) . Hellman et al (1965) studied the M. R. Wills effects of the intravenous administration of parathyroid extract and ofa purified parathyroid hormone on urinary acidification and on solute excretion in normal human subjects and thyro-parathyroidectomized dogs. In all their subjects there was an immediate rise in urinary pH and bicarbonate excretion with a fall in titrable-acid-minus-bicarbonate and ammonia following the intravenous injection, and this was usually associated with a rise in the urinary excretion of sodium and potassium. They considered that parathyroid hormone probably inhibited sodium for hydrogen-ion exchange in the renal tubules, perhaps by directly interfering with the ability of the kidney to maintain a hydrogen-ion gradient between the body fluids and the tubular urine. This tubular effect of parathyroid hormone on the hydrogen-ion gradient presumably accounts for the metabolic acidosis in the patients reported here.
The most likely explanation for the low plasma chloride concentration and alteration in acid-base status in the patients with hypercalcaemia due to causes other than primary hyperparathyroidism is renal tubular alkalosis. It has been shown that the acute intravenous infusion of calcium, either as chloride or gluconate, causes an increase in urinary hydrogen-ion excretion in both animals (Verbanck, 1965) and in man Lecestre, 1962 and . Richet and his colleagues (1963) reported that following a single intravenous injection of calcium salt, either as chloride or gluconate, in 16 adults the mean urinary pH fell from 6 75 to 5 11; this change was rapid in onset and continuedfor more than four hours after the injection. They postulated that this effect was due to an activation of renal tubular carbonic anhydrase activity by calcium . Such a factor, operating over a long period, could possibly cause a metabolic alkalosis of renal tubular origin. It is ofconsiderable interest that in patients with hypocalcaemia due to hypoparathyroidism it has recently been reported that there is a metabolic alkalosis (Barzel, 1969) which was attributed to the absence of parathyroid hormone. Barzel proposed that in the absence of parathyroid hormone there might be a failure in either the tubular reabsorption of hydrogen ions and/or citric acid formation. These two factors either individually or in combination resulting in a reduction of extracellular hydrogen-ion concentration. Such a hypothesis could also be postulated as playing a role in the aetiology of the metabolic alkalosis found in the patients with hypercalcaemia due to causes other than hyperparathyroidism in whom, presumably, endogenous parathyroid hormone secretion would be suppressed.
It is a possibility that calcitonin, which has an opposite action to parathyroid hormone on bone, may also have an opposite effect on the renal tubules and play a role in the production of the renal tubular alkalosis. On the kidney, however, calcitonin has a phosphaturic action similar to that of parathyroid hormone but does not affect the renal excretion of hydrogen ions in a reproducible manner (Ardaillou, Vuagnat, Milhaud, and Richet, 1967; Singer, Woodhouse, Parkinson, and Joplin, 1969; Cochran, Peacock, Sachs, and Nordin, 1970) . Calcitonin would not appear therefore to play a role in the aetiology of metabolic alkalosis in the patients with hypercalcaemia due to causes other than primary hyperparathyroidism.
The biochemical combination of hypercalcaemia and hypophosphataemia may occur in patients with non-endocrine-tissue hormone-secreting tumours, and this has been termed 'pseudo-hyperparathyroidism' (Fry, 1962; Snedecor and Baker, 1964; Lafferty, 1966) . Although immunologically similar to the naturally occurring hormone the parathyroid-likepolypeptide secreted by malignant tumours would appear to have some differing biological properties, as in these cases the hypercalcaemia is associated with a metabolic alkalosis. One of the patients reported here (case A) was classified as a case of 'pseudo-hyperparathyroidism'. The hypercalcaemia was associated with a low plasma chloride concentration and metabolic alkalosis (see Table II ). All of these biochemical abnormalities returned to normal values after radiotherapy and regression in tumour size. Reports in the literature with full simultaneous details of electrolyte and acid-base status in patients with hypercalcaemia of 'pseudo-hyperparathyroidism', associated with non-endocrine tumours are relatively few, and those that have been reported are detailed in Table V . From an inspection of (Wills, 1970 ) the only one that we have found of value is the cortisone suppression test (Dent, 1956; Dent and Watson, 1968) . Even this test is, however, not completely reliable as both suppression of the hypercalcaemia of primary hyperparathyroidism and non-suppression of that due to other causes has been reported (Dent, 1962; Pyrah et al, 1966; Avioli, 1968; Strott and Nugent, 1968; Garcia and Yendt, 1968) . The changes in plasma chloride concentration and acidbase status in patients with hypercalcaemia appear to offer a valuable index in the differentiation of the patients with hypercalcaemia due to primary hyperparathyroidism from those with hypercalcaemia due to all other causes. 
